NTRK1 fusions with TPM3, LMNA and TPR partners have been shown to be the most common ones in CRC [6, 7] and PLEKHA6::NTRK1 fusions have also previously been described in this disease [17, 18]. This evidence concerns the gene TPM3 and colorectal carcinoma.